Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North First Ventures is an Israel-based venture capital firm that invests in seed to Series A technology startups. The firm is commonly branded as N1V and focuses broadly on innovative technology companies rather than operating as a drug developer, healthcare company, or life sciences platform business. Available public profiles describe it as an active investor headquartered in Tel Aviv, with investments across software and other technology categories. It may invest opportunistically in health-related startups, but North First Ventures itself is not a biotech, pharma, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North First Ventures.